Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
Saved in:
| Title: | Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial. |
|---|---|
| Authors: | Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle., Deanfield JE; Institute of Cardiovascular Science, University College London, London, U.K., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA., Boesgaard TW; Novo Nordisk A/S, Søborg, Denmark., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, U.K., Kushner RF; Department of Medicine, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Burguera B; Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH., Gajos G; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland., Horn DB; Department of Surgery, John P. and Katherine G. McGovern Medical School, University of Texas, Houston, TX., Hramiak IM; Western University, London, Ontario, Canada., Jastreboff AM; Endocrinology and Metabolism, Department of Medicine, and Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT., Kokkinos A; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Maeng M; Department of Cardiology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Tinahones FJ; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), CIBERobn, and Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Málaga, Spain., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH., Ryan DH; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle.; Pennington Biomedical Research Center, Baton Rouge, LA. |
| Corporate Authors: | SELECT Trial Investigators |
| Source: | Diabetes care [Diabetes Care] 2024 Aug 01; Vol. 47 (8), pp. 1350-1359. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38907683 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kahn+SE%22">Kahn SE</searchLink>; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle.<br /><searchLink fieldCode="AU" term="%22Deanfield+JE%22">Deanfield JE</searchLink>; Institute of Cardiovascular Science, University College London, London, U.K.<br /><searchLink fieldCode="AU" term="%22Jeppesen+OK%22">Jeppesen OK</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Emerson+SS%22">Emerson SS</searchLink>; Department of Biostatistics, University of Washington, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Boesgaard+TW%22">Boesgaard TW</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Colhoun+HM%22">Colhoun HM</searchLink>; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, U.K.<br /><searchLink fieldCode="AU" term="%22Kushner+RF%22">Kushner RF</searchLink>; Department of Medicine, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Lingvay+I%22">Lingvay I</searchLink>; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Burguera+B%22">Burguera B</searchLink>; Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Gajos+G%22">Gajos G</searchLink>; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland.<br /><searchLink fieldCode="AU" term="%22Horn+DB%22">Horn DB</searchLink>; Department of Surgery, John P. and Katherine G. McGovern Medical School, University of Texas, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hramiak+IM%22">Hramiak IM</searchLink>; Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Jastreboff+AM%22">Jastreboff AM</searchLink>; Endocrinology and Metabolism, Department of Medicine, and Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Kokkinos+A%22">Kokkinos A</searchLink>; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Maeng+M%22">Maeng M</searchLink>; Department of Cardiology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Matos+ALSA%22">Matos ALSA</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Tinahones+FJ%22">Tinahones FJ</searchLink>; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), CIBERobn, and Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Lincoff+AM%22">Lincoff AM</searchLink>; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Ryan+DH%22">Ryan DH</searchLink>; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle.; Pennington Biomedical Research Center, Baton Rouge, LA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22SELECT+Trial+Investigators%22">SELECT Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2024 Aug 01; Vol. 47 (8), pp. 1350-1359. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38907683 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/dc24-0491 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1350 Titles: – TitleFull: Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kahn SE – PersonEntity: Name: NameFull: Deanfield JE – PersonEntity: Name: NameFull: Jeppesen OK – PersonEntity: Name: NameFull: Emerson SS – PersonEntity: Name: NameFull: Boesgaard TW – PersonEntity: Name: NameFull: Colhoun HM – PersonEntity: Name: NameFull: Kushner RF – PersonEntity: Name: NameFull: Lingvay I – PersonEntity: Name: NameFull: Burguera B – PersonEntity: Name: NameFull: Gajos G – PersonEntity: Name: NameFull: Horn DB – PersonEntity: Name: NameFull: Hramiak IM – PersonEntity: Name: NameFull: Jastreboff AM – PersonEntity: Name: NameFull: Kokkinos A – PersonEntity: Name: NameFull: Maeng M – PersonEntity: Name: NameFull: Matos ALSA – PersonEntity: Name: NameFull: Tinahones FJ – PersonEntity: Name: NameFull: Lincoff AM – PersonEntity: Name: NameFull: Ryan DH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1935-5548 Numbering: – Type: volume Value: 47 – Type: issue Value: 8 Titles: – TitleFull: Diabetes care Type: main |
| ResultId | 1 |